List of works - Madeleine M A Tilanus-Linthorst

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

scientific article published in July 2004

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

scientific article

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

scientific article published on 27 March 2013

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study

scientific article

Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients

scientific article published on October 6, 2015

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

scientific article published on 2 November 2011

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

scientific article published in December 2016

Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers

scientific article

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic

scientific article published on 31 May 2007

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

scientific article

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

scientific article

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer

scientific article published on 22 June 2006

Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: A prospective long-term follow-up study

article by Mariska den Heijer et al published June 2012 in European Journal of Cancer

Preoperative Breast MRI Can Reduce the Rate of Tumor-Positive Resection Margins and Reoperations in Patients Undergoing Breast-Conserving Surgery

scientific article published on February 1, 2013

Hereditary breast cancer growth rates and its impact on screening policy

scientific article

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

scientific article

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined

scientific article published on 28 June 2012

Psychological distress in women at increased risk for breast cancer: the role of risk perception

article by Silvia van Dooren et al published September 2004 in European Journal of Cancer

Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer

scientific article

Optimized nLC-MS workflow for laser capture microdissected breast cancer tissue

scientific article published on January 24, 2012

Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis

scientific article

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging

scientific article published on 12 August 2013

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)

scientific article published on April 17, 2015

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

scientific article published on 11 June 2015

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis

scientific article

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study

scientific article published on February 25, 2014

Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients

scientific article

9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium

scientific article published on 02 August 2012

Exploring the link between MORF4L1 and risk of breast cancer

scientific article

Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.

scientific article

Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer

Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy

scientific article

Long‐term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: a risk profile

scientific article published on February 7, 2012

The impact of social and personal resources on psychological distress in women at risk for hereditary breast cancer

scientific article published on 2 December 2010

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

scientific article

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

scientific article

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

scientific article

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study

scientific article published on 20 May 2014

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy

scientific article published on 14 January 2014

MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer.

scientific article

Optimal age to start preventive measures in women withBRCA1/2mutations or high familial breast cancer risk

scientific article published on 13 February 2013

Breast fine-needle aspiration cytology performance in the high-risk screening population: a study of BRCA1/BRCA2 mutation carriers

scientific article published on 29 May 2013

Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis

scientific article published on 5 September 2017

Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models

scientific article published on 15 June 2016

Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformation

scientific article

Choices for women at risk of hereditary breast cancer

scientific article published on January 1, 2013

List of works by Madeleine M A Tilanus-Linthorst

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study

Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer

Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: A prospective long-term follow-up study

Preoperative Breast MRI Can Reduce the Rate of Tumor-Positive Resection Margins and Reoperations in Patients Undergoing Breast-Conserving Surgery

Hereditary breast cancer growth rates and its impact on screening policy

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined

Psychological distress in women at increased risk for breast cancer: the role of risk perception

Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer

Optimized nLC-MS workflow for laser capture microdissected breast cancer tissue

Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study

Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients

9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium

Exploring the link between MORF4L1 and risk of breast cancer

Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.

Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer

Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy

Long‐term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: a risk profile

The impact of social and personal resources on psychological distress in women at risk for hereditary breast cancer

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy

MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer.

Optimal age to start preventive measures in women withBRCA1/2mutations or high familial breast cancer risk

Breast fine-needle aspiration cytology performance in the high-risk screening population: a study of BRCA1/BRCA2 mutation carriers

Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis

Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models

Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformation

Choices for women at risk of hereditary breast cancer

Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer